These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13631490)

  • 21. Hematological response to isologous and homologous bone marrow transplantation: mechanism of homologous failure.
    Kurnick NB; Nokay N
    Radiat Res; 1968 Oct; 36(1):31-44. PubMed ID: 17387924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental research on grafts of autologous and homologous marrow in the dog irradiated by lethal or suprelethal does].
    STECHER G; SULLIVAN R
    Sang; 1959; 30():782-3. PubMed ID: 13833946
    [No Abstract]   [Full Text] [Related]  

  • 23. Soluble factor(s) from bone marrow cells can rescue lethally irradiated mice by protecting endogenous hematopoietic stem cells.
    Zhao Y; Zhan Y; Burke KA; Anderson WF
    Exp Hematol; 2005 Apr; 33(4):428-34. PubMed ID: 15781333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on a biological radiation protection. XXVII. Effect of bone marrow transplantation in various mouse strains after x-irradiation.
    LANGENDORFF H; LANGENDORFF M; HAGEN U
    Strahlentherapie; 1958; 107(4):567-73. PubMed ID: 13615614
    [No Abstract]   [Full Text] [Related]  

  • 25. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow stromal cell line co-transfected with IL-2 and IL-3 genes can accelerate restoration of T-cell immunity in allo-BMT mice.
    Li AL; Jiang JY; Ma JB; Wang GM; Hao J; Gao X; Xie SS
    Chin Med J (Engl); 2004 Aug; 117(8):1223-7. PubMed ID: 15361299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kwon CH; Noh JH; Kim SJ
    Immunol Lett; 2006 Feb; 102(2):215-21. PubMed ID: 16260045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pathogenesis of the secondary disease after foreign bone marrow transplantation in X-irradiated mice.
    van BEKKUM D; VOS O; WEYZEN WW
    J Natl Cancer Inst; 1959 Jul; 23():75-89. PubMed ID: 13798388
    [No Abstract]   [Full Text] [Related]  

  • 29. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients.
    Prigozhina TB; Elkin G; Gurevitch O; Morecki S; Yakovlev E; Khitrin S; Slavin S
    Blood Cells Mol Dis; 2004; 33(3):238-47. PubMed ID: 15528138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for malignant tumors using combination of allogeneic intra-bone marrow-bone marrow transplantation, donor lymphocyte infusion and dendritic cells.
    Mukaide H; Adachi Y; Koike-Kiriyama N; Suzuki Y; Minamino K; Iwasaki M; Tsuda M; Nakano K; Koike Y; Shigematsu A; Kamiyama Y; Ikehara S
    Int J Oncol; 2007 Jun; 30(6):1309-15. PubMed ID: 17487350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells.
    Xu LH; Fang JP; Huang WG; Xu HG; Weng WJ; Kao GS; Le Y
    Bone Marrow Transplant; 2007 Oct; 40(7):691-8. PubMed ID: 17660838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of some genetic factors influencing irradiation protection by bone marrow.
    UPHOFF DE; LAW LW
    J Natl Cancer Inst; 1959 Feb; 22(2):229-41. PubMed ID: 13631491
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I; Murphy WJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.